Exabis Library
Welcome to the e-CCO Library!
P653: Ligation of the intersphincteric fistula tract vs. endorectal advancement flap for high perianal fistulas in Crohn’s disease: a retrospective cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P653: Rheumatic extraintestinal manifestations in ulcerative colitis : Prevalence and predictive factors
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P653: The changing epidemiology of IBD in the western world: a population-based study from Denmark
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P653: The efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P653: Tight control and Treat to target increase the rates of Transmural remission and Transmural response in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P654 Influence of the interval of time between anti-TNF and vedolizumab or ustekinumab in the response to treatment in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P654: Advances in optimalisation of therapeutic drug monitoring using mucosal TNF expression and anti-TNF concentration in patients with inflammatory bowel disease treated with biologicals: Preliminary results from a single-centre study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P654: Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P654: Controversies in the management of anti-TNF therapy in Crohn's disease patients. A Delphi consensus
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P654: Monitoring of drug concentrations to predict remission under ustekinumab induction therapy in Crohn's disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P654: Mucosal healing with a second anti-TNF-α in patients with ulcerative colitis after the failure of the previous anti-TNF-α treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P654: Prevalence of Inflammatory Bowel Disease in young Greek Army male recruits from 2006 to 2018: a thirteen-year retrospective study from a tertiary center
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P655 Pharmacokinetics of ustekinumab in children and adolescents with moderately to severely active Crohn’s disease: Results from UniStar, a phase 1 study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P655: A study to determine factors affecting clinical decision making in outpatients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P655: Early life mebendazole exposure increases the risk of adult-onset ulcerative colitis: a population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P655: Immunogenicity after transition from adalimumab to ABP 501 in patients with plaque psoriasis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P655: Insulin Resistance Prevalence is Not Increased in Patients with Inflammatory Bowel Disease: a case-control study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P655: MadCAM1 Negativity of Lamina Propria Endothelial Cells is Associated with Non-Response to Vedolizumab in Inflammatory Bowel Disease Patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P655: Microencapsulated Sodium Butyrate significantly modifies the microbiota in patients with inflammatory bowel disease mimicking prebiotic activity and proving effects on the treatment of the disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P656 Clinical implications of endoscopic submucosal dissection in management of patients with ulcerative colitis-associated dysplasia
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM